Mostrar el registro sencillo del ítem

dc.contributor.authorGonzalez-Rellan, M.J.
dc.contributor.authorFondevila, M.F.
dc.contributor.authorDiéguez González, Carlos
dc.contributor.authorNogueiras Pozo, Rubén
dc.date.accessioned2025-08-25T12:41:47Z
dc.date.available2025-08-25T12:41:47Z
dc.date.issued2022
dc.identifier.citationGonzalez-Rellan MJ, Fondevila MF, Dieguez C, Nogueiras R. O-GlcNAcylation: A Sweet Hub in the Regulation of Glucose Metabolism in Health and Disease. Frontiers in Endocrinology. Frontiers Media S.A.; 2022;13.
dc.identifier.issn1664-2392
dc.identifier.otherhttps://portalcientifico.sergas.gal/documentos/6289747affc02649ba306bb2*
dc.identifier.urihttp://hdl.handle.net/20.500.11940/20506
dc.description.abstractO-GlcNAcylation is a posttranslational modification ruled by the activity of a single pair of enzymes, O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA). These two enzymes carry out the dynamic cycling of O-GlcNAcylation on a wide range of cytosolic, nuclear, and mitochondrial proteins in a nutrient- and stress-responsive manner. To maintain proper glucose homeostasis, a precise mechanism to sense blood glucose levels is required, to adapt cell physiology to fluctuations in nutrient intake to maintain glycemia within a narrow range. Disruptions in glucose homeostasis generates metabolic syndrome and type 2 diabetes. In this review we will discuss and summarize emerging findings that points O-GlcNAcylation as a hub in the control of systemic glucose homeostasis, and its involvement in the generation of insulin resistance and type 2 diabetes.en
dc.description.sponsorshipThis work has been supported by grants from FEDER/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal de Investigacion (CD: BFU2017-87721; RN: RTI2018-099413-B-I00 and RED2018-102379-T), Xunta de Galicia (RN: 2015-CP080 and 2016-PG057), Fundacion BBVA (RN), Fundacion Atresmedia (RN), European Foundation for the Study of Diabetes (RN). This research also received funding from the European Community's H2020 Framework Programme (ERC Synergy Grant-2019-WATCH- 810331, to RN). CIBER de Fisiopatologia de la Obesidad y Nutricion (CIBERobn) is an initiative of the Instituto de Salud Carlos III (ISCIII) of Spain which is supported by FEDER funds.en
dc.language.isoeng
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleO-GlcNAcylation: A Sweet Hub in the Regulation of Glucose Metabolism in Health and Disease*
dc.typeReviewen
dc.authorsophosGonzalez-Rellan, R. M. J.
dc.authorsophosFondevila, M. F.
dc.authorsophosDieguez, C.
dc.authorsophosNogueiras
dc.identifier.doi10.3389/fendo.2022.873513
dc.identifier.sophos6289747affc02649ba306bb2
dc.issue.numbernull
dc.journal.titleFrontiers in Endocrinology*
dc.page.initialnull
dc.relation.projectIDFEDER/Ministerio de Ciencia; Innovacion y Universidades-Agencia Estatal de Investigacion [BFU2017-87721, RTI2018-099413-B-I00, RED2018-102379-T]; Xunta de Galicia [2015-CP080, 2016-PG057]; Fundacion BBVA; Fundacion Atresmedia; European Foundation for the Study of Diabetes; European Community's H2020 Framework Programme (ERC Synergy Grant) [2019-WATCH- 810331]; Instituto de Salud Carlos III (ISCIII) of Spain - FEDER funds
dc.relation.publisherversionhttps://www.frontiersin.org/articles/10.3389/fendo.2022.873513/pdf;https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.873513/pdfes
dc.rights.accessRightsopenAccess
dc.subject.keywordAS Santiagoes
dc.subject.keywordIDISes
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)es
dc.typesophosArtículo de Revisiónes
dc.volume.number13


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional